SYBX · XBRL financial data

Synlogic financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (SYBX's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	545	1,754	1,180	3,371	8	0
Research and development	47,474	47,127	52,044	43,971	9,154	43
General and administrative	13,537	15,392	16,555	14,561	6,631	3,489
Total operating expenses	61,011	62,519	68,599	58,532	40,958	4,008
Operating income (loss)	(60,466)	(60,765)	(67,419)	(55,161)	(40,950)	(4,008)
Interest expense	6	2	2	1	0	—
Other income (expense)	(3)	(4)	7	(517)	(2)	0
Income tax expense (benefit)	0	0	0	14	5	0
Net income (loss)	(59,173)	(60,561)	(66,147)	(57,282)	(23,359)	(1,005)
Earnings per share, basic USD per share	—	(1.09)	(0.92)	(8.81)	(1.92)	(0.08)
Earnings per share, diluted USD per share	—	(1.09)	(0.92)	(8.81)	(1.92)	(0.08)
Weighted average shares, basic thousands of shares	—	55,330	71,725	6,502	12,196	12,312
Weighted average shares, diluted thousands of shares	—	55,330	71,725	6,502	12,196	12,312

Fiscal years (SYBX's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	32,507	16,438	15,861	23,960	18,860	14,668
Marketable securities	67,937	112,150	61,768	23,786	0	—
Marketable securities, non-current	—	8,041	—	—	—	—
Prepaid and other current assets	6,402	4,721	2,153	2,161	830	729
Total current assets	106,846	133,309	79,782	49,907	19,776	15,397
Property and equipment, net	10,776	9,088	7,323	5,603	0	—
Right-of-use asset	15,527	13,889	14,356	12,102	0	—
Total assets	143,840	174,736	110,865	75,550	19,826	15,447
Accounts payable	1,995	1,944	1,785	1,457	164	103
Accrued liabilities	3,773	4,402	5,290	3,000	2,037	915
Total current liabilities	8,301	10,080	12,122	20,404	7,075	3,584
Lease liability, non-current	20,273	17,372	16,129	12,491	0	—
Accumulated deficit	(230,311)	(290,872)	(357,019)	(414,301)	(441,651)	(442,656)
Total stockholders' equity	115,135	147,266	82,610	42,655	12,751	11,863
Total liabilities and equity	143,840	174,736	110,865	75,550	19,826	15,447
Common shares outstanding (cover page) thousands of shares	39,658	70,228	67,728	11,647	11,696	11,699

Fiscal years (SYBX's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(59,173)	(60,561)	(66,147)	(57,282)	(23,359)	(1,005)
Stock-based compensation	3,907	3,361	3,639	2,806	3,169	117
Net cash from operating activities	(39,553)	(52,198)	(56,888)	(51,614)	(31,658)	(4,359)
Purchases of property and equipment	395	679	728	214	14	0
Net cash from investing activities	32,482	(53,253)	58,351	38,769	25,339	167
Proceeds from issuing common stock	—	81,042	0	—	—	—
Net cash from financing activities	13,394	89,382	(2,040)	20,944	172	0
Net change in cash	6,323	(16,069)	(577)	8,099	(6,147)	(4,192)

SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Synlogic	13,183	0	(922)*	12.2M	14.3 quarters	Q2 FY26 10-QJun 30, 2026
Matinas BioPharma Holdings	761	not reported	(1,836)*	14.7M	0.4 quarters	Q2 FY26 10-QJun 30, 2026
China Pharma Holdings	305	948	(33)*	43.0M	9.3 quarters	Q2 FY26 10-QJun 30, 2026
Soligenix	9,811	not reported	(1,707)*	21.8M	5.7 quarters	Q2 FY26 10-QJun 30, 2026
Target Group	14	1,381	(223)*	617.0M	0.1 quarters	Q2 FY26 10-QJun 30, 2026
Creative Medical Technology Holdings	8,714	0	(1,472)*	6.6M	5.9 quarters	Q2 FY26 10-QJun 30, 2026
Aspira Women's Health	477	17	(2,010)*	46.6M	0.2 quarters	Q2 FY26 10-QJun 30, 2026
Healthy Extracts	190	2,067	306*	14.7M	—	Q2 FY26 10-QJun 30, 2026
Viskase Holdings	7,747	95,279	454*	14.3M	—	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.